We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Companies' Letter Demands Biologic Bill Passage

Law360 (June 7, 2007, 12:00 AM EDT) -- In anticipation of an upcoming markup session, about 70 companies, associations and unions sent a letter sent to the two top members of the U.S. Senate Committee on Health, Education, Labor and Pensions, urging them to create a pathway for generic or follow-on biologic products.

The letter sent to Sens. Edward M. Kennedy (D-Mass.) and Mike Enzi (R-Wyo.) on Tuesday says that failure to create a pathway for the U.S. Food and Drug Administration to approve such products will allow for “an unacceptable continuation of monopoly...
To view the full article, register now.